Benralizumab: Cost-Effective Add-On Therapy for Refractory Eosinophilic Asthma Clinical Advisor, 22 Jun 2021 In patients with refractory eosinophilic asthma, treatment with benralizumab is a cost-effective option to be used as add-on…